These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. The post-translational modification, SUMOylation, and cancer (Review). Han ZJ; Feng YH; Gu BH; Li YM; Chen H Int J Oncol; 2018 Apr; 52(4):1081-1094. PubMed ID: 29484374 [TBL] [Abstract][Full Text] [Related]
3. Different proteomic strategies to identify genuine Small Ubiquitin-like MOdifier targets and their modification sites in Trypanosoma brucei procyclic forms. Iribarren PA; Berazategui MA; Bayona JC; Almeida IC; Cazzulo JJ; Alvarez VE Cell Microbiol; 2015 Oct; 17(10):1413-22. PubMed ID: 26096196 [TBL] [Abstract][Full Text] [Related]
4. A comprehensive compilation of SUMO proteomics. Hendriks IA; Vertegaal AC Nat Rev Mol Cell Biol; 2016 Sep; 17(9):581-95. PubMed ID: 27435506 [TBL] [Abstract][Full Text] [Related]
5. Molecular mechanisms in SUMO conjugation. Varejão N; Lascorz J; Li Y; Reverter D Biochem Soc Trans; 2020 Feb; 48(1):123-135. PubMed ID: 31872228 [TBL] [Abstract][Full Text] [Related]
6. Analysis of changes in SUMO-2/3 modification during breast cancer progression and metastasis. Subramonian D; Raghunayakula S; Olsen JV; Beningo KA; Paschen W; Zhang XD J Proteome Res; 2014 Sep; 13(9):3905-18. PubMed ID: 25072996 [TBL] [Abstract][Full Text] [Related]
7. The strategies for identification and quantification of SUMOylation. Zhang Y; Li Y; Tang B; Zhang CY Chem Commun (Camb); 2017 Jun; 53(52):6989-6998. PubMed ID: 28589199 [TBL] [Abstract][Full Text] [Related]
8. Rhes, a striatal enriched protein, regulates post-translational small-ubiquitin-like-modifier (SUMO) modification of nuclear proteins and alters gene expression. Rivera O; Sharma M; Dagar S; Shahani N; Ramĺrez-Jarquĺn UN; Crynen G; Karunadharma P; McManus F; Bonneil E; Pierre T; Subramaniam S Cell Mol Life Sci; 2024 Apr; 81(1):169. PubMed ID: 38589732 [TBL] [Abstract][Full Text] [Related]
9. SUMO-SIM interactions: From structure to biological functions. Lascorz J; Codina-Fabra J; Reverter D; Torres-Rosell J Semin Cell Dev Biol; 2022 Dec; 132():193-202. PubMed ID: 34840078 [TBL] [Abstract][Full Text] [Related]
10. Identification of SUMO target proteins by quantitative proteomics. Andersen JS; Matic I; Vertegaal AC Methods Mol Biol; 2009; 497():19-31. PubMed ID: 19107408 [TBL] [Abstract][Full Text] [Related]
11. Cancer-Associated Dysregulation of Sumo Regulators: Proteases and Ligases. Lara-Ureña N; Jafari V; García-Domínguez M Int J Mol Sci; 2022 Jul; 23(14):. PubMed ID: 35887358 [TBL] [Abstract][Full Text] [Related]
12. SUMOylation pathway in Trypanosoma cruzi: functional characterization and proteomic analysis of target proteins. Bayona JC; Nakayasu ES; Laverrière M; Aguilar C; Sobreira TJ; Choi H; Nesvizhskii AI; Almeida IC; Cazzulo JJ; Alvarez VE Mol Cell Proteomics; 2011 Dec; 10(12):M110.007369. PubMed ID: 21832256 [TBL] [Abstract][Full Text] [Related]
14. System-wide identification of wild-type SUMO-2 conjugation sites. Hendriks IA; D'Souza RC; Chang JG; Mann M; Vertegaal AC Nat Commun; 2015 Jun; 6():7289. PubMed ID: 26073453 [TBL] [Abstract][Full Text] [Related]
15. Site-specific identification and quantitation of endogenous SUMO modifications under native conditions. Lumpkin RJ; Gu H; Zhu Y; Leonard M; Ahmad AS; Clauser KR; Meyer JG; Bennett EJ; Komives EA Nat Commun; 2017 Oct; 8(1):1171. PubMed ID: 29079793 [TBL] [Abstract][Full Text] [Related]
16. Biosynthesis of SUMOylated Proteins in Bacteria Using the Trypanosoma brucei Enzymatic System. Iribarren PA; Berazategui MA; Cazzulo JJ; Alvarez VE PLoS One; 2015; 10(8):e0134950. PubMed ID: 26258470 [TBL] [Abstract][Full Text] [Related]
17. Sumoylation of heterogeneous nuclear ribonucleoproteins, zinc finger proteins, and nuclear pore complex proteins: a proteomic analysis. Li T; Evdokimov E; Shen RF; Chao CC; Tekle E; Wang T; Stadtman ER; Yang DC; Chock PB Proc Natl Acad Sci U S A; 2004 Jun; 101(23):8551-6. PubMed ID: 15161980 [TBL] [Abstract][Full Text] [Related]
18. The Role of SUMO E3 Ligases in Signaling Pathway of Cancer Cells. Shi X; Du Y; Li S; Wu H Int J Mol Sci; 2022 Mar; 23(7):. PubMed ID: 35408996 [TBL] [Abstract][Full Text] [Related]
19. SUMO-Binding Entities (SUBEs) as Tools for the Enrichment, Isolation, Identification, and Characterization of the SUMO Proteome in Liver Cancer. Lopitz-Otsoa F; Delgado TC; Lachiondo-Ortega S; Azkargorta M; Elortza F; Rodríguez MS; Martínez-Chantar ML J Vis Exp; 2019 Nov; (153):. PubMed ID: 31736480 [TBL] [Abstract][Full Text] [Related]
20. Identification of a new small ubiquitin-like modifier (SUMO)-interacting motif in the E3 ligase PIASy. Kaur K; Park H; Pandey N; Azuma Y; De Guzman RN J Biol Chem; 2017 Jun; 292(24):10230-10238. PubMed ID: 28455449 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]